Total System Services Reaches New 52-Week High (TSS)

NEW YORK ( TheStreet) -- Total System Services (NYSE: TSS) hit a new 52-week high Wednesday as it is currently trading at $21.72, above its previous 52-week high of $20.99 with 303,728 shares traded as of 9:35 a.m. ET. Average volume has been 1.3 million shares over the past 30 days.

Total System Services has a market cap of $4.17 billion and is part of the services sector and diversified services industry. Shares are up 7.1% year to date as of the close of trading on Tuesday.

Total System Services, Inc. provides electronic payment processing and other services to card-issuing and merchant acquiring institutions. The company has a P/E ratio of 19.4, equal to the average diversified services industry P/E ratio and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Total System Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Total System Services Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus